Logotype for Sutro Biopharma Inc

Sutro Biopharma (STRO) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Sutro Biopharma Inc

Proxy filing summary

23 Apr, 2026

Voting matters and shareholder proposals

  • Election of three Class II directors: Jane Chung, Connie Matsui, and James Panek, with board recommending a vote for all nominees.

  • Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended for approval.

  • Advisory vote to approve compensation of named executive officers, with board recommending approval.

Board of directors and corporate governance

  • Board is seeking shareholder approval for the election of three Class II directors at the 2026 annual meeting.

Executive compensation and say-on-pay

  • Advisory vote on executive compensation is included, allowing shareholders to express approval or disapproval of named executive officer pay.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more